Live Breaking News & Updates on Nureca share price

Stay informed with the latest breaking news from Nureca share price on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nureca share price and stay connected to the pulse of your community

Nureca Share Price, Nureca Stock Price, Nureca Ltd. Stock Price, Share Price, Live BSE/NSE, Nureca Ltd. Bids Offers. Buy/Sell Nureca Ltd. news & tips, & F&O Quotes, NSE/BSE Forecast News and Live Quotes

Nureca Share Price: Find the latest news on Nureca Stock Price. Get all the information on Nureca with historic price charts for NSE / BSE. Experts & Broker view also get the Nureca Ltd. buy/sell tips detailed news, announcements, Forecasts, Analysts, Valuation, Earning forecasts, Estimates, Recommendations, Analysts Ratings, financial report, company information, annual report, balance sheet, profit & loss account, results and more.

Goregaon , Maharashtra , India , Mumbai , Delhi , New-delhi , Alankit-assignment-ltd , Office-no , Udyog-bhavan , Sonawala-lane , Goregaon-east

Nureca share price: This recent debutant of D-Street is on a high, jumps 150% in 2 months

Explore Now
New Delhi: The second wave of Covid-19 cases in India has badly hit investor sentiment on Dalal Street. However, a recent debutant has defied gravity and delivered up to 150 per cent return over issue price in just one-and-a-half months.
The stock is Nureca, a healthcare and wellness products distributor company, which got listed at Rs 634.95 at a 58.74 per cent premium to its issue price of Rs 400 on February 25, 2021. The stock has surged to trade at Rs 951 on Friday, April 16.
Nureca is a leading player of products that are in high demand due to Coronavirus. The second wave of the pandemic has increased demand for products like oximeters, thermometers, BP monitors, nebulisers and multivitamins, say analysts and market watchers.

India , New-delhi , Delhi , Gaurav-garg , Head-of-research-at-capitalvia-global , Yash-gupta-equity-research , Capitalvia-global , Yash-gupta-equity-research-associate , Nureca-share-price , Nureca-ltd , Covid-cases , Nureca-ipo

This recently-listed healthcare stock has zoomed 132% against issue price

Shares of the recently-listed healthcare supplies company Nureca rallied 10 per cent and hit a new high of Rs 929 on the BSE on Monday in an otherwise weak market. At 01:48 pm, it was trading 7 per cent higher at Rs 906, against 3.5 per cent decline in the S&P BSE Sensex.
In the past three days, the stock of the home healthcare and wellness products provider has jumped 36 per cent and soared 132 per cent against its issue price of Rs 400 per share. Nureca’s Rs 100-crore IPO had seen more than 40 times oversubscription.
As per the shareholding pattern, out of the 30 per cent public shareholding, institutional investors held 18.72 per cent stake in Nureca. Individual shareholders held 5.87 per cent holding, while bodies corporate and Yash Shares and Stock Private Limited held 5.30 per cent and 4.41 per cent stake, respectively.

India , Tata-group , Stock-private , Yash-shares , Stock-private-limited , Pulse-oximeters , Nureca-share-price , Markets , Health-care , Ipo , Nureca

Nureca share price: Stocks in the news: Nureca, Dr Reddy's Labs, Affle India, Max Financial and HGS

Explore Now
Nifty futures on the Singapore Exchange traded 209 points, or 1.41 per cent, higher at 15,073.50 in signs that Dalal Street was headed for a gap-up start on Thursday. Here are a few stocks whihc may buzz the most in today's trade:
Dr Reddy's Labs: The subject expert committee under India’s drug regulator has not cleared the application of Dr Reddy’s Laboratories seeking approval to market the Sputnik V Covid-19 vaccine, citing lack of data.
Nureca: The company, which is into the business of home healthcare and wellness products, will make market debut today. The Rs 100 crore IPO, which was sold from February 15 to Ferbuary 17, was subscribed 39.93 times. The category meant for qualified institutional buyers (QIBs) was subscribed 3.10 times, non institutional investors 31.59 times and retail individual investors (RIIs) 166.65 times.

India , United-kingdom , London , City-of , Singapore , Pantone-finvest , Max-financial-services-ltd , Axis-bank , Nokia , Hinduja-group , Punjab-national-bank , Affle-holdings-pte-ltd

Stocks to watch: Nureca, Max Fin, Axis Bank, DRL, Dredging Corp, Affle

Here are the top stocks that are likely to be in focus today:
Nureca: Shares of Nureca will list on the bourses today. The IPO by home healthcare and wellness products provider that ran between February 15-17 witnessed 40 times subscription.
Max Financial Services, Axis Bank: The Insurance Regulatory and Development Authority of India (IRDAI) has given its approval for the acquisition of up to 12 per cent stake in Max Life Insurance by Axis Bank and its subsidiaries Axis Capital and Axis Securities.
Affle (India): Affle Holdings Pte Ltd, a promoter of Affle (India), on Wednesday, offloaded 3 lakh shares of the company worth over Rs 161 crore through an open market transaction.

Cochin , Kerala , India , Netherlands , Switzerland , Singapore , Holland , Piramal-pharma , Diego-massidda , Infrastructure-developers , Axis-bank , Max-financial-services

Nureca IPO: Nureca makes strong debut, lists at 59% premium over issue price

Explore Now
NEW DELHI: Nureca Limited on Thursday made a strong debut on BSE, as the scrip got listed at Rs 634.95, a premium of 58.74 per cent over its issue price of Rs 400. On NSE, the shares listed at Rs 615.00 apiece, a 53.75 per cent premium over the issue price.
At the issue price, the stock was priced at a P/E of 62.55 times on its earnings per share of Rs 6.40.
The Rs 100 crore IPO by the home healthcare and wellness products maker was open for subscription from February 15 to February 17. The issue was subscribed 39.93 times in total.
The B2C company received bids for 5,59,65,945 shares against 14,01,595 shares on offer, according to NSE data. The category meant for qualified institutional buyers (QIBs) was subscribed 3.10 times, and that for non-institutional investors 31.59 times. The portion reserved for retail individual investors (RIIs) saw subscription of 166.65 times.

India , Nureca-ebitda , Nureca-limited-on , Nureca-limited , Nureca-ipo , Nureca-ltd , Nureca-ipo-status , Nureca-stock-price , Nureca-share-price , Nureca-shares , Nureca-ipo-news , Nureca-ipo-price

Nureca IPO: Nureca IPO allotment status: Here's how to check it

The issue, which was sold from February 15 to February 17, had received a solid 166.65 times retail bids.

India , Link-intime-india-private-ltd , Nureca-ipo , Nureca-news , Nureca-stock-price , Nureca-listing , Nureca-share-price , Nureca-shares , இந்தியா , இணைப்பு-நேர-இந்தியா-ப்ரைவேட்-லிமிடெட் ,

Nureca IPO allotment status online, Nureca IPO allotment status, Nureca IPO listing date, Nureca IPO share price

Home healthcare and wellness brand Nureca will finalise the share allotment of its Rs 100-crore initial public offer (IPO) on Tuesday. The IPO, which was open for bidding for three days from February 15 to February 17, was subscribed 39.92 times.

Issue-name-nureca , Image-source , Issue-name , Nureca-limited , Nureca-ipo , Nureca-share-price , Nureca-ipo-listing-date , Nureca-ipo-listing-gain , Nureca-ipo-listing-price , Nureca-ipo-allotment-status , Nureca-ipo-allotment-status-check

Nureca IPO: Nureca's Rs 100-crore IPO kicks off. Should you subscribe?

Employees of the company are being offered a discount of Rs 20 per share.

India , Nureca-ebitda , Yash-gupta , Equity-research-associate-at-angel-broking , Equity-research-associate , Angel-broking , Nureca-ipo-review , Nureca-ltd , Nureca-ipo , Nureca-stock-price , Nureca-share-price , Nureca-ipo-details

Nureca IPO kicks off today: Check price band, issue size & other details; should you subscribe?

Nureca IPO kicks off today: Check price band, issue size & other details; should you subscribe?
The company has reserved shares worth Rs 1 crore for its employees. The eligible employees will get shares at a discount of Rs 20 per share
BusinessToday.In | February 15, 2021 | Updated 12:01 IST
The company has already garnered Rs 44.55 crore from two anchor investors on February 12. Equity shares will be listed on BSE and NSE
The sixth initial public offering in the calendar 2021- Nureca IPO opens for subscription on February 15 and will close on February 17.
The company plans to raise Rs 100 crore via public issue. The price band for the public issue has been fixed at Rs 396-400 per equity share at face value of Rs 10 each. Investors can bid for a minimum of 35 equity shares and in multiples of 35 shares thereafter and up to 14 lots.

Yash-gupta , Reliance-research , Equity-research , Research-associate , Angel-broking , Chronic-device-products , Orthopedic-products , Child-products , Nutrition-supplements , Nureca-ipo , Nureca-gmp , Nureca-ipo-gmp